Lafora bodies in skeletal muscle are fiber type specific
- PMID: 21451149
- PMCID: PMC3100090
- DOI: 10.1212/WNL.0b013e318219faf6
Lafora bodies in skeletal muscle are fiber type specific
Figures

Similar articles
-
Development of polyglucosan inclusions in skeletal muscle.Neuromuscul Disord. 2006 Oct;16(9-10):603-7. doi: 10.1016/j.nmd.2006.05.259. Epub 2006 Aug 21. Neuromuscul Disord. 2006. PMID: 16919952
-
Metabolic and phenotypic characteristics of human skeletal muscle fibers as predictors of glycogen utilization during electrical stimulation.Eur J Appl Physiol. 2005 Oct;95(4):276-82. doi: 10.1007/s00421-005-0003-x. Epub 2005 Oct 27. Eur J Appl Physiol. 2005. PMID: 16096841
-
Glycogen hyperphosphorylation underlies lafora body formation.Ann Neurol. 2010 Dec;68(6):925-33. doi: 10.1002/ana.22156. Ann Neurol. 2010. PMID: 21077101
-
Muscle fiber type diversity revealed by anti-myosin heavy chain antibodies.FEBS J. 2018 Oct;285(20):3688-3694. doi: 10.1111/febs.14502. Epub 2018 May 24. FEBS J. 2018. PMID: 29761627 Review.
-
Maximizing Cellular Adaptation to Endurance Exercise in Skeletal Muscle.Cell Metab. 2018 May 1;27(5):962-976. doi: 10.1016/j.cmet.2018.04.014. Cell Metab. 2018. PMID: 29719234 Review.
Cited by
-
Brain Glycogen Structure and Its Associated Proteins: Past, Present and Future.Adv Neurobiol. 2019;23:17-81. doi: 10.1007/978-3-030-27480-1_2. Adv Neurobiol. 2019. PMID: 31667805 Free PMC article. Review.
-
Myofiber-type-dependent 'boulder' or 'multitudinous pebble' formations across distinct amylopectinoses.Acta Neuropathol. 2024 Feb 27;147(1):46. doi: 10.1007/s00401-024-02698-x. Acta Neuropathol. 2024. PMID: 38411740
-
Suppression of glycogen synthesis as a treatment for Lafora disease: Establishing the window of opportunity.Neurobiol Dis. 2021 Jan;147:105173. doi: 10.1016/j.nbd.2020.105173. Epub 2020 Nov 7. Neurobiol Dis. 2021. PMID: 33171226 Free PMC article.
-
Activation of serum/glucocorticoid-induced kinase 1 (SGK1) underlies increased glycogen levels, mTOR activation, and autophagy defects in Lafora disease.Mol Biol Cell. 2013 Dec;24(24):3776-86. doi: 10.1091/mbc.E13-05-0261. Epub 2013 Oct 16. Mol Biol Cell. 2013. PMID: 24131995 Free PMC article.
-
Lafora Disease: A Review of Molecular Mechanisms and Pathology.Neuropediatrics. 2018 Dec;49(6):357-362. doi: 10.1055/s-0038-1675238. Epub 2018 Oct 18. Neuropediatrics. 2018. PMID: 30336494 Free PMC article. Review.
References
-
- Turnbull J. Glycogen hyperphosphorylation underlies Lafora body formation. Ann Neurol 2010; 68: 925–933 - PubMed
-
- Andrade DM, Ackerley CA, Minett TS, et al. Skin biopsy in Lafora disease: genotype-phenotype correlations and diagnostic pitfalls. Neurology 2003; 61: 1611–1614 - PubMed
-
- McDermott JC, Bonen A. Glyconeogenic and oxidative lactate utilization in skeletal muscle. Can J Physiol Pharmacol 1992; 70: 142–149 - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources